ALLOX closed a €9.4 million seed round to expand its drug discovery platform, AI models, team and small-molecule pipeline.
- Amount
- $10.5M
- Stage
- Seed
- Announced
- 29 October 2026
- Lead
- Asabys
- Other investors
- CDTI, SICC Innvierte, Institut Català de Finances (ICF)
- Use of funds
- Scale and expand platform, develop proprietary AI models, and advance internal small-molecule drug discovery pipeline.
- Checked
- Matched to an official SEC filing